Skye Bioscience Net Non-Operating Interest Income Expense (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.727 -0.05 (-6.79%) USD | NASDAQ | Dec 30, 16:00

0.6997 -0.03 (-3.76%) Pre-Market: 09:28

View Net Non-Operating Interest Income Expense (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	Upgrade
Theravance Biopharma, Inc.	Upgrade
Viking Therapeutics, Inc.	Upgrade
FibroGen, Inc.	Upgrade
Myomo, Inc.	Upgrade